Skip to main content
. 2024 Apr 5;22:86. doi: 10.1186/s12957-024-03371-z

Table 1.

Clinicopathological characteristics of patients with RGC

Variables RGC (n = 38)
Sex
 Female 10 (26%)
 Male 28 (74%)
Age Mean ± SD (years) 72.9 ± 9.1
Body composition Mean ± SD (kg/m2) 21.4 ± 3.2
Initial gastric disease
 Benign 12 (32%)
 Malignant 26 (68%)
Initial procedure
 Distal gastrectomy 38 (100%)
Interval between first and second surgeries
 Median (years) 19 (1–53)
Reconstruction of initial surgery
 Billroth I 22 (58%)
 Billroth II 12 (32%)
 Roux-en-Y 4 (10%)
Depth of tumor
 T1 21 (55%)
 T2 9 (24%)
 T3 8 (21%)
Lymph node metastasis
 N0 36 (95%)
 N1 0 (0%)
 N2 2 (5%)
Stage
 I 28 (74%)
 II 10 (26%)
Histological type
 Well 13 (35%)
 Moderate 10 (26%)
 Poor 8 (21%)
 Sig 7 (18%)
Lymphatic invasion
 Negative 26 (68%)
 Positive 12 (32%)
Venous invasion
 Negative 30 (79%)
 Positive 8 (21%)
Surgical approach
 Laparotomy 38 (100%)
 Surgical procedure
 Total gastrectomy 38 (100%)
Combined resection
 Spleen 11 (28%)
 Gallbladder 8 (20%)
 Distal pancreas 2 (5%)
 Colon 1 (3%)
Operative time
 Median (min) 336 (174–612)
Estimated blood loss
 Median (g) 550 (24–2512)

RGC remnant gastric cancer, SD standard deviation